Delix Therapeutics Closes $30 - GuruFocus.com
GuruFocus Article or News written by PRNewswire and the topic is about:
Stay updated with breaking news from Mark Rus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GuruFocus Article or News written by PRNewswire and the topic is about:
/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological...
/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological...
/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for serious psychiatric and...
/PRNewswire/ -- Delix Therapeutics (the "Company") is honored to have been named by Fierce Biotech as one of 2021's "Fierce 15" biotechnology companies,...